Stage 01
Preparation and anaesthesia
Prepare the auricular donor area and establish the sterile field according to the current professional protocol.
Technology & pathway
From a tissue-specific sample to a point-of-care suspension.
Professional overview
Mytocel MSK uses documented mechanical disaggregation to prepare autologous cartilage micrografts without laboratory expansion or enzymatic digestion.
Autologous micrografting technology
The tissue context remains part of the story.
The supplied material describes a heterogeneous suspension containing cartilage-derived cells, extracellular-matrix components and biological signals from the donor tissue.
01
Cartilage origin
A small sample is obtained from auricular cartilage.
02
Tissue-derived components
Cellular and extracellular-matrix components are carried from the source tissue.
03
Mechanical processing
Rigenera technology prepares micrografts with a documented 80 μm cut-off.
04
Same clinical pathway
The resulting suspension is collected for professional use without laboratory culture.
Protocol orientation
Four controlled stages.
This sequence explains how the stages relate. It does not replace formal training, current instructions for use, clinical judgement or the controlled professional protocol.
Stage 02
Cartilage sampling
Obtain three small samples from the auricular cartilage using the documented professional technique.
Stage 03
Disaggregation and collection
Process the samples in Rigeneracons® RS using the calibrated machine cycle, then collect the prepared suspension.
Stage 04
Professional administration
Administer the suspension to the target joint within the same point-of-care pathway.
System components
Two core devices. One documented workflow.
Reusable
N4SA processing machine
The reusable unit provides the calibrated impulse used during the defined processing cycle.
Class IIa · single use
Rigeneracons® RS
A sterile, single-use Class IIa device in the supplied professional documentation, designed to mechanically disaggregate solid human tissue.
Product classification, labelling, intended purpose and UK market status should always be checked against current manufacturer documentation before use.
Clinical boundaries
Professional judgement remains authoritative.
Patient selection, contraindications, sterile technique, supporting consumables, administration and aftercare belong to the treating clinician and the current professional documentation.
01
Qualified use
The supplied protocol is intended for appropriately qualified healthcare professionals.
02
Controlled documents
Current instructions, device labelling and training take precedence over website orientation.
03
Evidence-aware claims
Mechanistic rationale should not be presented as proof of individual clinical outcome.
Professional enquiries
Discuss the Mytocel MSK pathway with Actomed.
Ask about the professional pack, clinic setup, product configuration and training in the UK.